A. Batra, S.E. Collins, I. Torchalla, M. Schröter, and G. Buchkremer (2008) showed that smokers reporting higher levels of nicotine dependence, novelty seeking/hyperactivity, and depressivity (i.e., at-risk smokers) evinced higher rates of posttreatment smoking than smokers reporting lower scores on self-report psychological symptom measures (i.e., lower risk smokers). This study aimed to replicate the smoker subgroups and test the comparative effectiveness of standard pharmacobehavioral smoking cessation versus modified smoking cessation matched to at-risk smokers' needs. On the basis of their self-report responses, adult regular smokers (N = 268) were classified into smoker subgroups. At-risk smokers were randomly assigned to receive the standard or modified treatments; lower risk smokers received standard treatment. Modified treatment produced higher abstinence rates than the standard treatment for depressive smokers but not for other at-risk smokers. Overall, abstinence rates among at-risk smokers receiving modified treatment were not significantly different from those of lower risk smokers; however, abstinence among higher dependence smokers receiving modified treatment decreased at higher rates than among lower risk smokers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jsat.2009.08.003 | DOI Listing |
JMIR Cardio
December 2024
Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
Health care is under pressure due to an aging population with an increasing prevalence of chronic diseases, including cardiovascular disease. Smoking and physical inactivity are 2 key preventable risk factors for cardiovascular disease. Yet, as with most health behaviors, they are difficult to change.
View Article and Find Full Text PDFPsychooncology
December 2024
Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Objective: The diagnosis of a mood-related psychiatric disorder (MRPD) among patients with cancer has been associated with decreased quality of life and lower cancer survival. This study aimed to understand the risk of a new MRPD after cancer diagnosis by individual risk behaviors, with a specific focus on tobacco use and the presence of a human papillomavirus (HPV)-associated cancer.
Methods: Single-center retrospective cohort study of 11,712 patients diagnosed with cancer between 2009 and 2020.
J Vasc Surg
December 2024
Division of Vascular and Endovascular Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Objectives: For men ages 65-75 without a smoking history and for women ages 65-75 with a smoking history, the US Preventative Service Task Force recommends that primary care providers (PCP) use their clinical judgement when offering abdominal aortic aneurysm (AAA) screening. This study describes the trends in screening for these cohorts, identify factors that may influence screening rates, and compare outcomes between screened and unscreened patients.
Methods: The TriNetX population database was queried for subjects with routine PCP visit between ages 65-75 from 2007-2023 to create cohorts of male smokers, male non-smokers, and female smokers.
GMS Hyg Infect Control
November 2024
HBT Medical College and Dr. RN Cooper Hospital Juhu, Mumbai, India.
Introduction: Smoking and tuberculosis are the two major, global health problems. Not only active smokers but also passive smokers are at risk of becoming infected with tuberculosis. Through many mechanisms, smoking decreases immunity and predisposes to numerous infections.
View Article and Find Full Text PDFNicotine Tob Res
December 2024
Department of Public Health, Medical University of South Carolina, Charleston SC.
Introduction: Genetic studies of smoking cessation have been limited by short-term follow-up or cross-sectional design. Within seven genes (CHRNA3, CHRNA5, CHRNB2, CHRNB4, DRD2, DBH and CYP2A6) influencing biological mechanisms relevant to smoking, this study aimed to identify single nucleotide polymorphisms (SNPs) associated with smoking cessation throughout up to 38-years of follow-up.
Methods: Participants were from two all-female cohort studies, Nurses' Health Study (NHS) (n = 10,017) and NHS-2 (n = 2,793).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!